CHRONIC MUCUS HYPERSECRETION AND CHRONIC OBSTRUCTIVE LUNG DISEASE THE MOST DISABLING HEALTH EFFECTS OF TOBACCO

 

Conclusion
It is now very glaring that there are enomous adverse effects of tobacco smoking both to voluntary smokers and passive smokers. With chronic mucus hypersecretion and chronic obstructive lung disease being enlisted as one of these effects and also the must disabling effects. It is therefore advised that better measures to control and restrict the smoking of tobacco especially in public places should be developed. As this will help to reduce the treat it currently posess on public health ( especially the high rate of chronic mucus hypersecretion and chronic obstructive lung disease occurrence caused by tobacco).

Referenes:
1. Drug and Alcohol Services South Australia (DASSA ). Tobacco and Its Effects, 2010. dassa.sa.gov.au/site/ [accessed 2013 August 20].
2. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2011. Geneva: World Health Organization, 2011 [accessed 2013 August 20].
3. Centers for Disease Control and Prevention. Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 2000–2004. Morbidity and Mortality Weekly Report  2008;57(45):1226–8.
4. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2011.
5. Fielding, JE and Phenow, KL. New England Journal of Medicine 1988; 319: 1452-60
6. Caumo, W, et al, “Risk factors for preoperative anxiety in adults,” Acta Anaestheiologica Scandinavica 45(3):298-307, March 2001.
7. Parrott, AC, “Does Cigarette Smoking Cause Stress?,” American Psychologist 54(10):817-20, October 1999.
8. Campaign for Tobacco free Kids. Smoking's Immediate Effect on the Body. tobaccofreekids.org/facts_issues/fact_sheets/toll/products
9. Trauth, JA, “An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions,” Brain Research, 867(1-2):29-39, June 2000
10. Mitchell, B, et al., “Tobacco Use and Cessation: The Adverse Health Effects of Tobacco and Tobacco-Related Products,” Primary Care: Clinics in Office Practice 26(3):463-98, September 1999.
11. Primatesta, P, et al., “Association between smoking and blood pressure,” Hypertension 37:187-193, 2001.
12. Righetti, M & Sessa, A, “Cigarette smoking and kidney involvement,” Journal of Nephrology, 14(1):3-6, January-February 2001
13. Fitzpatrick, TM & Blair, EA, “Smoking and pulmonary and Cardiovascular Disease: Upper Airway Complications of Smoking,” Clinics in Chest Medicine 21(1):147-157, March 2000;  Kadakia, SC, et al., “Original contributions: Effect of Cigarette smoking on Gastroesophageal Reflux Measured by 24 h Ambulatory Esophageal pH Monitoring,” American Journal of Gastroenterology  90(10):1785-1791, October 1995; Kahrilas, PJ, “Mechanisms of acid reflux associated with cigarette smoking,” Gut 31(1):4-10, January 1990
14. Brodish, PH, “The Irreversible Health Effects of Cigarette Smoking,” The American  Council on Science & Health, June 1998; Fitzpatrick, TM & Blair, EA, “Smoking and pulmonary and Cardiovascular Disease: Upper Airway Complications of Smoking,” Clinics in Chest Medicine 21(1):147-157, March 2000; Kadakia, SC, et al., “Original contributions: Effect of Cigarette smoking on Gastroesophageal Reflux Measured by 24 h Ambulatory Esophageal pH Monitoring,” American Journal of Gastroenterology  90(10):1785-1791, October 1995; Karilas, 1990; Wo, JM and Waring, JP, “Medical Therapy of Gastroesophageal Reflux and Management of Esophageal Strictures,” Surgical Clinics of North America 77(5):1041-62, October 1997.
15. Fitzpatrick, TM & Blair, EA, “Smoking and pulmonary and Cardiovascular Disease: Upper Airway Complications of Smoking,” Clinics in Chest Medicine 21(1):147-157, March 2000; Katz, PO, “Gastroesophageal Reflux Disease,” Journal of the American Geriatrics Society 46(12):1558-65, December 1998.
16. Falk, GW, “Barrett’s esophagus,” Gastroenterology 122(6):1569-91, May 2002.
17. Mitchell, B, et al., “Tobacco Use and Cessation: The Adverse Health Effects of Tobacco and Tobacco-Related Products,” Primary Care: Clinics in Office Practice 26(3):463-98, September 1999; Cotran, Robbins Pathologic Basis of Disease, 6th Edition, 499-503, 1999; Coroll, Primary Care Medicine, 3rd Edition, 1995; Sabiston, 1997
18. Katz, PO, “Gastroesophageal Reflux Disease,” Journal of the American Geriatrics Society 46(12):1558-65, December 1998; Belfiglio, G, “’Breath Mint’. Two words are the centerpiece of HealthPartners’ successful anti-tobacco campaign, the winner of AAHP’s Community Leadership Award,” Healthplan 38(4):46-52,54, July-August 1997; Lamkin, L & Houston, TP, “Adolescent Medicine: Nicotine Dependency & Adolescents: Preventing & Treating,” Primary Care, 25(1):123-35, March 1998; U.S. Preventive Services Task Force, Guidelines from Guide to Clinical Preventive Services, Second Edition,1996.
19. Goldman, Cecil Textbook of Medicine, 21st Edition, 2000; Feldman, Sleisenger and Fordtrans’ Gastrointestinal & Liver Disease, Sixth Edition, 1998.
20. Goldman, Cecil Textbook of Medicine, 21st Edition, 2000.
21. Gidding, SS, “Pediatric Cardiology; Preventive Pediatric Cardiology- Tobacco, Cholesterol, Obesity, and Physical Activity,” Pediatric Clinics of North America 46(2):253-262, April 1999.
22. Behrman: Nelson Textbook of Pediatrics, Sixteenth Edition, Copyright 2000 W.B. Saunders Company; Brodish, PH, “The Irreversible Health Effects of Cigarette Smoking,” The American Council on Science & Health, June 1998.  
23. Behrman: Nelson Textbook of Pediatrics, Sixteenth Edition, Copyright 2000 W.B. Saunders Company; Brodish, PH, “The Irreversible Health Effects of Cigarette Smoking,” The American Council on Science & Health, June 1998; Mitchell, B, et al., “Tobacco Use and Cessation: The Adverse Health Effects of Tobacco and Tobacco-Related Products,” Primary Care: Clinics in Office Practice 26(3):463-98, September 1999; U.S. Department of Health & Human Services (HHS), Preventing Tobacco Use Among Young People: A Report of the Surgeon General, 1994. 16 Behrman: Nelson Textbook of Pediatrics, Sixteenth Edition, Copyright
24. Behrman: Nelson Textbook of Pediatrics, Sixteenth Edition, Copyright 2000 W.B. Saunders Company; HHS, Preventing Tobacco Use Among Young People: A Report of the Surgeon General, 1994.
25. Takeyama, K, et al, “Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke,”   American Journal of Physiology:  Lung Cellular & Molecular Physiology, 280(1):L165-72, January 2001.  Maestrelli, P, et al, “Remodeling in response to infection and injury. Airway inflammation and hypersecretion of mucus in smoking subjects with chronic obstructive pulmonary disease,” American of Respiratory & Critical Care Medicine 164(10 Pt 2):S76-80, November 15, 2001
26. Laurence D.R, Bennett P.N and Brown M.J. Clinical Pharmaclogy, Eight Edition, Churchill Livingstone, 1998.
27. Barnes PJ. Chronic obstructive pulmonary disease. New England Journal of Medicine 2000;343.269-280.
28. Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 1999;5.93-99.
29. Hurd S. The impact of COPD on lung health worldwide. Chest 2000;117 (suppl):1S-4S

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT articles@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE


Pages

FIND MORE ARTICLES